Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
AssigneeZengen, Inc.
InventorsAnna Pia Catania, James M. Lipton
Life of this patent
Estimating the term…
Loading patent…
AssigneeZengen, Inc.
InventorsAnna Pia Catania, James M. Lipton
Estimating the term…
α-MSH and other amino acid sequences derived from α-MSH were determined to have antimicrobial influences, including against two major and representative cutaneous and mucosal pathogens; Staphylococcus aureus and Candida albicans, Pharmaceutical compositions useful as antimicrobial agents, including for use in reducing the viability of microbes, reducing the germination of yeasts, killing microbes without reducing the killing of microbes by human neutrophils, for treating inflammation in which there is microbial infection without reducing microbial killing, and for increasing the accumulation of cAMP in microbes are disclosed. The antimicrobial agent is selected from the group consisting of one or more peptides including the amino acid sequence KPV, one or more peptides including the amino acid sequence MEHFRWG, or a biologically functional equivalent of any of the foregoing. The most effective of the peprides were those bearing the C-terminal amino acid sequence of α-MSH. i.e., α-MSH (1-13), (6-13), and (11-13).
A method for reducing the viability of microbes comprising exposing the microbes to an antimicrobial agent selected from the group consisting of KPV (SEQ ID NO:
A method for reducing the germination of yeast comprising exposing the yeast to an antimicrobial agent selected from the group consisting of KPV (SEQ ID NO:
A method for killing microbes comprising exposing the microbes to an antimicrobial agent selected from the group consisting of KPV (SEQ ID NO:
A method for increasing the accumulation of cAMP in microbes comprising exposing the microbes to an antimicrobial agent an selected from the group consisting of KPV (SEQ ID NO:
A method for treating a microbial infection comprising exposing the microbes to an antimicrobial agent selected from the group consisting of KPV (SEQ ID NO:
Dependencies are inferred from the claim text.